KPJ Healthcare, Japanese firms explore Indonesian oncology centre venture

PETALING JAYA: KPJ Healthcare Bhd has teamed up with Japanese firms to explore the possibility of developing and operating an oncology centre in Indonesia at an estimated cost of US$12 million (RM48.3 million).
In a filing with Bursa Malaysia yesterday, it said that its wholly owned subsidiary Kumpulan Perubatan (Johor) Sdn Bhd (KPJSB) has signed a memorandum of understanding (MoU) with Sojitz Corp and Capital Medica Co Ltd of Japan.
The MoU sets out the tri-partite collaboration between the three parties to study the proposed opening of the oncology centre at Rumah Sakit Medika Bumi Serpong Damai (RSMBSD).
KPJ said the oncology centre has the potential to offer a wide range of cancer management services to the locals and will enhance the services available at RSMBSD, as well as create more employment opportunities.
In addition, the collaboration will facilitate the sharing and transferring of medical technology and know-how between Japan, Malaysia and Indonesia.